Conferences Vivet Therapeutics is attending in 2026
Vivet Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: ESGCT 2026 (on the program) and BIO-Europe 2026 (on the program). Vivet Therapeutics develops AAV gene therapies for rare genetic diseases, including Wilson disease. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
ESGCT 33rd Annual CongressEurope’s gene & cell therapy researchersOfficial site |
Hamburg, Germany ~2.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 posters Attendee mix: Mostly academic; gene and cell therapy PIs, postdocs and clinicians, strong biotech and CDMO presence
Attending
|
Open the guide Search and filter attendees |
BIO-Europe 2026European biotech partnering & BDOfficial site |
Cologne, Germany ~5.8k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 panel discussion Attendee mix: Almost entirely industry; European biotech and pharma BD executives, licensing teams and investors
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Vivet Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Vivet Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!